Compare UGRO & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UGRO | EVGN |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 10.9M |
| IPO Year | N/A | N/A |
| Metric | UGRO | EVGN |
|---|---|---|
| Price | $0.38 | $1.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $3.50 |
| AVG Volume (30 Days) | ★ 2.8M | 47.8K |
| Earning Date | 03-27-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $59,985,138.00 | $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.40 | $12.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $0.21 | $0.95 |
| 52 Week High | $1.30 | $2.42 |
| Indicator | UGRO | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 67.56 | 44.07 |
| Support Level | $0.23 | $1.07 |
| Resistance Level | $0.25 | $1.19 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 86.02 | 34.08 |
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.